Panome Bio offers an advanced tissue-based discovery proteomics platform that enables deep, unbiased profiling of proteins directly from tissues — delivering a high-resolution window into cellular function and disease mechanisms. Leveraging optimized LC-MS workflows for complex tissue matrices (fresh, frozen and preserved), our technology delivers exceptional protein coverage and reproducibility across conditions and experimental cohorts.

Our platform supports key applications such as biomarker discovery, pathway mapping, drug target validation, and translational research in oncology, neuroscience and precision medicine.

Advantages of Our Tissue-Based Discovery Proteomics Offering

Compatible with a wide range of sample types (tissues, cells, biofluids and more)

Simultaneous multi-protein targeting, enabling large-scale proteome profiling

Requires minimal sample volume/weight: as little as ~25 µL or ~10 mg sample input

High throughput: upward of 5,000-7,000 protein identifications achievable

Designed for complex biological matrices and translationally-relevant cohorts

Unlock deep mechanistic insight into your research — from tissue proteome profiling to integrated multi-omic interpretation.

Start exploring tissue-based discovery proteomics with Panome Bio on CROaccess today.